CLS CELESTICA INC
Printed Circuit Boards · NYSE · SEC CIK 1030894 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY61.6%
TTM net income YoY73.8%
TTM EPS YoY72.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin11.5%
Operating margin8.3%
Net margin6.8%
FCF margin3.0%
EBITDA margin9.3%
Returns
ROE30.2%
ROA11.5%
ROIC (approx.)46.2%
Asset turnover1.68x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.13x
Current ratio1.61x
Interest coverage20.36x
Cash quality & payout
Operating cash flow / net income1.13x
Accruals ratio-1.5%
Payout ratio—
Capex / revenue4.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $12.39B | $9.65B |
| Cost of revenue | $10.90B | $8.61B |
| Gross profit | $1.49B | $1.03B |
| R&D expense | $118.20M | $78.00M |
| SG&A expense | $259.90M | $293.50M |
| Operating income | $1.04B | $599.30M |
| Interest expense | $52.60M | $52.10M |
| Pretax income | $983.20M | $532.20M |
| Income tax | $150.70M | $104.20M |
| Net income | $832.50M | $428.00M |
| EBITDA | $1.22B | $751.20M |
| EPS (basic) | 7.22 | 3.62 |
| EPS (diluted) | 7.16 | 3.61 |
| Weighted avg. shares (diluted) | 116.20M | 118.70M |
| Balance sheet | ||
| Cash & equivalents | $595.60M | $423.30M |
| Inventory | $2.19B | $1.76B |
| Current assets | $5.67B | $4.51B |
| PP&E, net | $586.00M | $537.20M |
| Goodwill | $333.10M | $340.50M |
| Intangibles | $266.20M | $308.00M |
| Total assets | $7.21B | $5.99B |
| Current liabilities | $3.94B | $3.02B |
| Short-term debt | $26.00M | $26.50M |
| Long-term debt | $750.50M | $770.20M |
| Total debt | $776.50M | $796.70M |
| Total liabilities | $5.00B | $4.09B |
| Shareholders' equity | $2.22B | $1.90B |
| Net debt | $180.90M | $373.40M |
| Shares outstanding | 114.91M | 116.07M |
| Cash flow statement | ||
| Operating cash flow | $659.50M | $473.90M |
| Capital expenditure | $201.20M | $170.90M |
| Free cash flow | $458.30M | $303.00M |
| Investing cash flow | -$203.70M | -$212.50M |
| Financing cash flow | -$283.50M | -$208.50M |
| Depreciation & amortization | $175.70M | $151.90M |
| Stock-based compensation | $69.80M | $57.40M |
| Share buybacks | $153.40M | $152.00M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.